Figure 2
From: Cytosolic protein delivery using pH-responsive, charge-reversible lipid nanoparticles
Size distribution and Cryo-TEM observation of NLS-(− 30)GFP-LNP formulations. (A) NLS-(− 30)GFP-LNPs (1:10), (B) NLS-(− 30)GFP-LNPs (1:50) and (C) LNPs formed without using NLS-(− 30)GFP [LNPs (no NLS-(− 30)GFP)]. (i) Size distribution of NLS-(− 30)GFP-LNPs analyzed using DLS. (ii) The morphology of NLS-(− 30)GFP-LNPs was observed via Cryo-TEM technology. (iii) The magnified image of (ii). Scale bars 50 nm.
